Patents by Inventor Shiuan-Huei Wu

Shiuan-Huei Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF BACILLUS COAGULANS BC198 OR ITS METABOLITES FOR PREVENTION OR ADJUVANT TREATMENT OF INTESTINAL LESION-RELATED PATHOLOGICAL CHANGES OR FLORA IMBALANCE CAUSED BY CHEMOTHERAPY
    Publication number: 20230293601
    Abstract: The invention discloses a use of Bacillus coagulans BC198 or its metabolites for prevention or adjuvant treatment of intestinal lesion-related pathological changes or flora imbalance caused by chemotherapy, that is, by administering an effective amount of Bacillus coagulans BC198 to an individual receiving chemotherapy is capable of effectively improving disorders of weight loss, loss of appetite, diarrhea, shortening of length of large intestine, inflammation, intestinal tissues lesion and imbalance of intestinal flora caused by chemotherapeutic drugs, in other words, the Bacillus coagulans BC198 disclosed in the invention can be used as an adjuvant product, a dietetic food product for chemotherapy, or other compositions for improving side effects or enhancing therapeutic effects.
    Type: Application
    Filed: May 4, 2022
    Publication date: September 21, 2023
    Inventors: Wei-Jen CHEN, Tsung-Yin TANG, Shiuan-Huei WU, Ai-Lun TSENG, Siou-Ru SHEN
  • COMBINATION OF PROBIOTICS WITH LACTICASEIBACILLUS PARACASEI S38 AND BACILLUS COAGULANS BC198 AND APPLICATIONS THEREOF FOR IMPROVING BODY COMPOSITIONS
    Publication number: 20230210919
    Abstract: A combination of probiotics for improving body compositions includes Lacticaseibacillus paracasei S38 and Bacillus coagulans BC198. The combination of probiotics can be a medicine composition, a nutrient supplement, healthy food or a combination thereof. The applications of the combination of probiotics include weight loss, reduction of fat, abatement of appetite, production of butyric acid within intestinal tracts and anf increased count of Akkermansia muciniphila or Ruminococcaceae inside intestines.
    Type: Application
    Filed: October 6, 2021
    Publication date: July 6, 2023
    Inventors: Wei-Jen Chen, Hui-Fang Chu, Yu-Lun Tsai, Shiuan-Huei Wu, Chi-Fai Chau
  • strain V3 and its efficacies of intestinal microflora regulation, anti-inflammation and cancer prevention
    Patent number: 11529382
    Abstract: The present invention provides a novel Lactobacillus fermentum strain, named Lactobacillus fermentum strain V3, and its use in manufacturing a pharmaceutical composition or a food composition for regulating intestinal microflora and treating and/or preventing an inflammatory diseases and/or a cancer.
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: December 20, 2022
    Assignee: SYNGEN BIOTECH. CO., LTD.
    Inventors: Wei-Jen Chen, Shiuan-Huei Wu, Chiau-Ling Gung, Yu-Lun Tsai
  • strain ST4 and its efficacies of anti-inflammation and cancer prevention
    Patent number: 11458164
    Abstract: The present invention provides a novel Streptococcus thermophilus strain ST4, and its use in manufacturing a medicament and/or food composition for treating and/or preventing an inflammatory disease and/or a cancer.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: October 4, 2022
    Assignee: SYNGEN BIOTECH CO., LTD.
    Inventors: Wei-Jen Chen, Shiuan-Huei Wu, Chiau-Ling Gung, Yu-Lun Tsai
  • LACTOBACILLUS FERMENTUM STRAIN V3 AND ITS EFFICACIES OF INTESTINAL MICROFLORA REGULATION, ANTI-INFLAMMATION AND CANCER PREVENTION
    Publication number: 20210023149
    Abstract: The present invention provides a novel Lactobacillus fermentum strain, named Lactobacillus fermentum strain V3, and its use in manufacturing a pharmaceutical composition or a food composition for regulating intestinal microflora and treating and/or preventing an inflammatory diseases and/or a cancer.
    Type: Application
    Filed: July 24, 2020
    Publication date: January 28, 2021
    Applicant: Syngen Biotech. Co., Ltd.
    Inventors: Wei-Jen CHEN, Shiuan-Huei WU, Chiau-Ling GUNG, Yu-Lun TSAI
  • STREPTOCOCCUS THERMOPHILUS STRAIN ST4 AND ITS EFFICACIES OF ANTI-INFLAMMATION AND CANCER PREVENTION
    Publication number: 20210023130
    Abstract: The present invention provides a novel Streptococcus thermophilus strain ST4, and its use in manufacturing a medicament and/or food composition for treating and/or preventing an inflammatory disease and/or a cancer.
    Type: Application
    Filed: July 23, 2020
    Publication date: January 28, 2021
    Applicant: Syngen Biotech. Co., Ltd.
    Inventors: Wei-Jen Chen, Shiuan-Huei Wu, Chiau-Ling Gung, Yu-Lun Tsai